麻豆传媒

Meeting Coverage >

NAMS

Flibanserin: Not Just for Premenopausal Women Anymore?

Sheryl Kingsberg, PhD, urges clinicians to ask patients about sexual concerns

Menopause May Be Risk Period for Chronic Pain, Opioid Use

Study looked at cohort of women veterans

NAMS: 'Take the Fear Out' of Hormone Therapy

JoAnn Pinkerton, MD, breaks down the highlights of NAMS updated position statement

Study Counters WHI on Risk of Hormones in Menopause

Hormone therapy may actually help the heart in some respects for newly menopausal women, a randomized trial showed, although the impact on hard outcomes like stroke and breast cancer still remains to be seen.